ANTHONY HARALABATOS: Open Payments
NPI 1174603401 · SALEM, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,827 in 57 payments from 14 companies in 2025. Trend: 2023 $949 · 2024 $867 · 2025 $1,827
Food & beverage: $1,827
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $576 |
| ABBVIE INC. | 15 | $248 |
| Braeburn Inc. | 9 | $247 |
| Amgen Inc. | 3 | $164 |
| Lilly USA, LLC | 7 | $160 |
| Alkermes, Inc. | 1 | $112 |
| Merck Sharp & Dohme LLC | 3 | $85 |
| Exact Sciences Corporation | 2 | $49 |
| Gilead Sciences, Inc. | 2 | $48 |
| Collegium Pharmaceutical, Inc. | 2 | $42 |
Products named: BREZTRI, BRIXADI, VRAYLAR, AIRSUPRA, WAINUA, REPATHA, VIVITROL, MOUNJARO.
Industry payments across NH — which companies pay providers there.
